Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

This study has been withdrawn prior to enrollment.
(Could not obtain drug supply from manufacturer)
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Information provided by:
University of Virginia
ClinicalTrials.gov Identifier:
NCT01343641
First received: July 29, 2010
Last updated: April 25, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)